Novavax (NVAX) News Today $7.84 +0.21 (+2.75%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$7.88 +0.04 (+0.57%) As of 08/22/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NVAX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Novavax Shares Are Trading Higher Thursday: What's Going On?August 22 at 4:36 PM | benzinga.comWhat the Options Market Tells Us About NovavaxAugust 22 at 4:35 PM | benzinga.comBank of America Reiterates Underperform Rating for Novavax (NASDAQ:NVAX)August 22 at 8:48 AM | marketbeat.comNovavax Announces $225M Convertible Senior Notes IssuanceAugust 21 at 8:51 AM | tipranks.comNovavax announces convertible debt refinancingAugust 21 at 8:10 AM | seekingalpha.comNovavax Announces Convertible Debt RefinancingAugust 21 at 7:43 AM | prnewswire.comFox Run Management L.L.C. Invests $479,000 in Novavax, Inc. $NVAXAugust 21 at 4:08 AM | marketbeat.comB of A Securities Downgrades Novavax (NVAX)August 20 at 8:35 PM | msn.comStock Traders Buy Large Volume of Novavax Call Options (NASDAQ:NVAX)August 20 at 3:46 PM | marketbeat.comBofA downgrades Novavax stock on vaccine uncertaintyAugust 20 at 3:34 PM | in.investing.comNovavax downgraded to Underperform from Neutral at BofAAugust 20 at 3:34 PM | msn.comNu double upgraded, Novavax downgraded: Wall Street's top analyst callsAugust 20 at 3:34 PM | finance.yahoo.comNovavax downgraded to Underperform at BofA on growth uncertaintiesAugust 20 at 3:34 PM | msn.comNovavax (NASDAQ:NVAX) Shares Gap Up - Should You Buy?August 20 at 1:21 PM | marketbeat.comEntropy Technologies LP Invests $191,000 in Novavax, Inc. (NASDAQ:NVAX)August 18, 2025 | marketbeat.comNovavax (NASDAQ:NVAX) Trading 5.4% Higher - Here's What HappenedAugust 16, 2025 | marketbeat.comNovavax (NASDAQ:NVAX) Trading Down 5.7% - Here's WhyAugust 12, 2025 | marketbeat.comB. Riley Comments on Novavax's FY2027 Earnings (NASDAQ:NVAX)August 12, 2025 | marketbeat.comXTX Topco Ltd Buys Shares of 67,803 Novavax, Inc. (NASDAQ:NVAX)August 10, 2025 | marketbeat.comNovavax Stock Surges Amid Strategic GainsAugust 10, 2025 | msn.comFDA reinstates top vaccines regulator just days after his abrupt departureAugust 9, 2025 | msn.comTD Cowen Reaffirms Their Hold Rating on Novavax (NVAX)August 8, 2025 | theglobeandmail.comNovavax (NASDAQ:NVAX) Stock Price Up 14.6% After Better-Than-Expected EarningsAugust 8, 2025 | marketbeat.comNovavax, Inc. (NASDAQ:NVAX) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | msn.comNovavax (NASDAQ:NVAX) Shares Gap Up Following Earnings BeatAugust 7, 2025 | marketbeat.comNovavax lifts 2025 revenue outlook after FDA milestone paymentAugust 7, 2025 | finance.yahoo.comNovavax banks on vaccine supply partnerships to boost 2025 revenueAugust 7, 2025 | msn.comNovavax higher after Q2 beat as partnerships brighten outlookAugust 7, 2025 | msn.comDecoding Novavax Inc (NVAX): A Strategic SWOT InsightAugust 6, 2025 | gurufocus.comQ2 2025 Novavax Inc Earnings Call TranscriptAugust 6, 2025 | gurufocus.comNovavax (NVAX) Profit Jumps on MilestoneAugust 6, 2025 | fool.comNovavax (NVAX) Reports Q2 Progress and Key Partnership DevelopmentsAugust 6, 2025 | gurufocus.comNovavax Ups Outlook, Eyes Stronger Nuvaxovid SalesAugust 6, 2025 | benzinga.comNovavax Reports Second Quarter 2025 Financial Results and Operational Highlights | NVAX Stock NewsAugust 6, 2025 | gurufocus.comNovavax Inc (NVAX) Q2 2025 Earnings: EPS of $0.62 Beats Estimate, Revenue Surges to $239 MillionAugust 6, 2025 | gurufocus.comNovavax (NVAX) Surpasses Earnings Expectations with Revenue BoostAugust 6, 2025 | gurufocus.comNovavax Reports Second Quarter 2025 Financial Results and Operational HighlightsAugust 6, 2025 | gurufocus.comNovavax (NVAX) Raises Revenue Forecast Amid Strong Vaccine PartnershipsAugust 6, 2025 | gurufocus.comNovavax (NVAX) Boosts 2025 Revenue Outlook Amid Strategic CollaborationsAugust 6, 2025 | gurufocus.comNVAX Earnings: Novavax Stock Rallies on Upbeat Annual Revenue ForecastAugust 6, 2025 | tipranks.comNovavax beats quarterly revenue estimates on milestone paymentAugust 6, 2025 | reuters.comNovavax Reports Second Quarter 2025 Financial Results and Operational HighlightsAugust 6, 2025 | prnewswire.comNovavax, Inc. (NASDAQ:NVAX) Given Consensus Rating of "Hold" by AnalystsAugust 6, 2025 | marketbeat.comNovavax (NVAX) Prepares for Q2 Earnings Report Amid Earnings HistoryAugust 5, 2025 | gurufocus.comNovavax Q2 2025 Earnings PreviewAugust 5, 2025 | seekingalpha.comJupiter Asset Management Ltd. Takes $1.91 Million Position in Novavax, Inc. (NASDAQ:NVAX)August 5, 2025 | marketbeat.comNovavax (NVAX) Projected to Post Quarterly Earnings on WednesdayAugust 1, 2025 | marketbeat.comNovavax poised to end in red for seventh straight sessionAugust 1, 2025 | seekingalpha.comNovavax Stock Dips As Moderna's Woes Weigh On Vaccine SectorAugust 1, 2025 | benzinga.comBayforest Capital Ltd Takes $404,000 Position in Novavax, Inc. (NASDAQ:NVAX)August 1, 2025 | marketbeat.com Get Novavax News Delivered to You Automatically Sign up to receive the latest news and ratings for NVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address NVAX Media Mentions By Week NVAX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVAX News Sentiment▼0.420.66▲Average Medical News Sentiment NVAX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVAX Articles This Week▼1811▲NVAX Articles Average Week Get Novavax News Delivered to You Automatically Sign up to receive the latest news and ratings for NVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Moderna News Ocugen News Vaxart News Johnson & Johnson News Pfizer News Alkermes News Ligand Pharmaceuticals News Amicus Therapeutics News BioCryst Pharmaceuticals News Celldex Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NVAX) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novavax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novavax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access